Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTC896 Gel for Sebum Reduction in Healthy Males
NCT01254162Phase 2Completed
- Sponsor
- Mimetica
- Start
- Jul 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MTC-896, sponsored by Mimetica. Started Jul 2010; status: completed.
02
Drugs
MTC-896
Beyond the preview
Go deeper on NCT01254162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254162.